Investment
Scientific Venture Partners invested in QBiotix, which has raised $323K. 20/20 HealthCare Partners also invested.
QBiotix
Added recently
3 milestones· JAN 2026 – SEP 2026
Milestone
AHA/ASA 2026 Guideline now recognizes Pharyngeal Electrical Stimulation (PES) for stroke rehabilitation. Phagenesis' Phagenyx System is the first and only commercially available system delivering PES. The guideline was published August 27, 2026 in Stroke.
Phagenesis
SEP 2, 2026
Milestone
Atlantic Health introduced Phagenyx as an advanced therapy for post-stroke swallowing disorders.
Phagenesis
MAY 10, 2026
Milestone
Pharyngeal electrical stimulation (PES) therapy included in 2026 AHA/ASA guideline for acute ischemic stroke management.
Phagenesis
JAN 26, 2026